Monica Marie Guggenberger, MS LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 1406 6th Avenue North, St. Cloud Hospital, St. Cloud, MN 56303 Phone: 320-251-2700 Fax: 320-656-7115 |
Mary Kaye Tacker, PHD, LMFT, LADC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Avenue North, St. Cloud Hospital, St. Cloud, MN 56303 Phone: 320-251-2700 Fax: 320-229-5109 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.
The National Institutes of Health has awarded more than $2 million to a team of scientists from Washington University in St. Louis and InvivoSciences, a biotechnology startup with WUSTL roots, to construct artificial tissue models that will allow the rapid testing of new drugs for heart failure.
It had long been assumed that the human sperm cell's mission in life ended once it had transferred its freight of parental DNA to the egg. More recently however, other components of sperm have been implicated in fertilization, and perhaps even in subsequent embryonic development.
Chronic kidney disease is a global health concern, affecting about 10 percent of the world's population-and increasing in prevalence. A final, common pathway in chronic kidney disease is fibrosis.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).
› Verified 4 days ago